Go Pro
OTCMKTS:TRUMY

Terumo (TRUMY) Stock Price, News & Analysis

Terumo logo
$14.16 -0.52 (-3.54%)
As of 09/18/2026 03:58 PM Eastern

About Terumo Stock (OTCMKTS:TRUMY)

Advanced

Key Stats

Today's Range
$13.90
$14.33
50-Day Range
$13.05
$16.67
52-Week Range
$12.08
$17.81
Volume
69,250 shs
Average Volume
59,158 shs
Market Capitalization
$20.89 billion
P/E Ratio
19.94
Dividend Yield
0.78%
Price Target
N/A
Consensus Rating
Buy

Company Overview

Terumo Corporation is a Japan-based medical technology company that develops, manufactures and sells products used in hospitals, clinics and other health care settings. Founded in 1921, the company has grown from producing clinical thermometers into a global provider of medical devices and related solutions.

Terumo’s businesses include cardiovascular and vascular intervention products, such as catheters, guidewires and other devices used in the treatment of heart and vascular conditions. The company also supplies blood management products, including blood bags and automated systems, as well as hospital products such as syringes, infusion systems and injection-related devices. In addition, Terumo develops technologies for therapeutic areas including neurovascular care, aortic treatment and cell and gene therapies.

Terumo serves health care providers and patients in Japan and international markets across the Americas, Europe, Asia and other regions. Its products are marketed through a combination of direct operations, subsidiaries and distribution networks, supporting medical professionals in areas including cardiovascular care, blood management and general hospital practice.

AI Generated. May Contain Errors.

Receive TRUMY Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Terumo and its competitors with MarketBeat's FREE daily newsletter.

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

TRUMY Stock News Headlines

Terumo ADR (TRUMY)
NVDA CEO says it’s a "once-in-a-generation opportunity"
NVIDIA CEO Jensen Huang calls a little-known AI niche a once-in-a-generation opportunity, and it has nothing to do with chips or ChatGPT. Huang says AI is moving off computers and into the real world, calling it the dawn of a new industrial revolution. Matt McCall, who flagged NVDA at $6 before it climbed 3,100% in six years, reveals his top pick in this emerging space.tc pixel
Terumo ADR Stock Price History
Terumo Corporation (TRUMY) Q3 2026 Earnings Call Transcript
See More Headlines

TRUMY Stock Analysis - Frequently Asked Questions

Terumo's stock was trading at $14.49 at the beginning of the year. Since then, TRUMY stock has decreased by 2.3% and is now trading at $14.16.

Terumo Corp. (OTCMKTS:TRUMY) posted its earnings results on Friday, August, 7th. The company reported $0.30 EPS for the quarter, beating analysts' consensus estimates of $0.17 by $0.13. The company had revenue of $1.97 billion for the quarter, compared to analysts' expectations of $1.84 billion. Terumo had a trailing twelve-month return on equity of 10.44% and a net margin of 13.83%.

Terumo shares split on Thursday, March 28th 2024.The 2-1 split was announced on Thursday, March 28th 2024. The newly issued shares were distributed to shareholders after the closing bell on Thursday, March 28th 2024. An investor that had 100 shares of stock prior to the split would have 200 shares after the split.

Shares of TRUMY stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Company Calendar

Last Earnings
8/07/2026
Today
9/20/2026
Next Earnings (Estimated)
11/11/2026
Fiscal Year End
3/31/2027

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Industry
Healthcare Equipment & Supplies
Sub-Industry
N/A
Current Symbol
OTCMKTS:TRUMY
Previous Symbol
NASDAQ:TRUMY
CIK
1446672
Employees
30,000
Year Founded
1964

Profitability

EPS (Trailing Twelve Months)
$0.71
Trailing P/E Ratio
19.94
Forward P/E Ratio
20.23
P/E Growth
N/A
Net Income
$897.03 million
Net Margins
13.83%
Pretax Margin
15.75%
Return on Equity
10.44%
Return on Assets
7.34%

Debt

Debt-to-Equity Ratio
0.13
Current Ratio
2.19
Quick Ratio
1.37

Sales & Book Value

Annual Sales
$7.52 billion
Price / Sales
2.78
Cash Flow
$1.04 per share
Price / Cash Flow
13.63
Book Value
$7.09 per share
Price / Book
2.00

Miscellaneous

Outstanding Shares
1,475,070,000
Free Float
N/A
Market Cap
$20.89 billion
Optionable
Not Optionable
Beta
0.68

Social Links

7 Best Space Stocks to Own in 2026 Cover

The space race is growing fast, and you don’t have to have gotten in early on SpaceX to profit. This report shows seven space stocks you can buy today that may grow as rockets, satellites, defense, space internet, and new space technology become more important.

Get This Free Report

This page (OTCMKTS:TRUMY) was last updated on 9/20/2026 by MarketBeat.com Staff.
From Our Partners